Clinical Trials
159
Active:59
Completed:90
Trial Phases
6 Phases
Early Phase 1:1
Phase 1:86
Phase 2:14
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (126 trials with phase data)• Click on a phase to view related trials
Phase 1
86 (68.3%)Phase 2
14 (11.1%)Phase 4
9 (7.1%)Not Applicable
8 (6.3%)Phase 3
8 (6.3%)Early Phase 1
1 (0.8%)Efficacy and Tolerability of Tasipimidine in Sleepless Patients
- First Posted Date
- 2025-05-04
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 153
- Registration Number
- NCT06956495
- Locations
- 🇫🇮
Terveystalo Helsinki Uniklinikka, Helsinki, Finland
Two-part, First-in-Human Study on ODM-212 in Subjects with Selected Advanced Solid Tumours
- First Posted Date
- 2024-12-10
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 315
- Registration Number
- NCT06725758
- Locations
- 🇬🇧
Royal Marsden Hospital, London, UK, London, United Kingdom
Efficacy and Safety of Remo-Wax® Oil (RWO) in Subjects With Isolated Itching of the External Ear Canal
Not Applicable
Completed
- Conditions
- Itching
- First Posted Date
- 2023-04-13
- Last Posted Date
- 2023-10-06
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 36
- Registration Number
- NCT05811039
- Locations
- 🇱🇹
Vilnius University Hospital, Vilnius, Lithuania
Study to Compare Relative Bioavailability of 3 Indacaterol/Glycopyrronium Test Products and Reference Product
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Drug: Indacaterol/glycopyrronium
- First Posted Date
- 2022-03-18
- Last Posted Date
- 2022-07-13
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 24
- Registration Number
- NCT05288075
- Locations
- 🇫🇮
CRST Helsinki Oy, Helsinki, Finland
Comparison of Tiotropium Absorption From Tiotropium Easyhaler and Spiriva HandiHaler
- First Posted Date
- 2022-02-18
- Last Posted Date
- 2022-08-18
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 88
- Registration Number
- NCT05246046
- Locations
- 🇫🇮
Clinical Pharmacology Unit, Orion Corporation, Espoo, Finland
- Prev
- 1
- 2
- 3
- 4
- 5
- 20
- Next
News
No news found